Cell therapy weekly: Severe spinal cord injury trial demonstrates favorable safety and improved motor function
News In Brief: The State of the Registry Report 2018
Member Exclusive INFOGRAPHIC NEWS ROUND-UP
Cell therapy weekly: CCRM and GE Healthcare to assist in scale-up of degenerative disc disease therapy
In this interview, filmed at the World Advanced Therapies and Regenerative Medicine Congress (16–18 May, London, UK), Hatim Hemeda, CEO, PL Bioscience, discusses the importance of xeno-free cell culture media.